Companies / BioMarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc

Nasdaq: BMRNCIK 1048477NOVATO, CAbiomarin.com ↗

Financials · FY2025

Revenue$3.22B
Net income$348.90M
Total debt$4.19B
Cash$874.00M
Diluted EPS$1.80
Shares outstanding193.6M

Ownership

193.6M shares outstanding · as of Jul 28, 2026
0.52%Insiders
Ownership
Insiders0.52%1,015,600
10%+ / strategic14.30%27,673,970
Institutions89.57%173,381,087
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 17

View all →
Insider% of sharesShares
Hardy AlexanderCEOChief Executive Officer · Director
0.11%214,635
Meier Richard aDirector
0.07%126,926
Mueller BrianEVP, Chief Financial Officer
0.06%123,314
Guyer Charles GregEVP, Chief Technical Officer
0.04%84,140
Davis George EricEVP, Chief Legal Officer
0.04%78,560
Friberg Gregory REVP, Chief R&D Officer
0.03%51,818
Hombach Robert J.Director
0.03%49,360
Dere Willard HDirector
0.02%46,440
Hubbard CristinEVP, Chief Commercial Officer
0.02%42,472
Anderson Elizabeth MDirector
0.02%41,940

Institutional holders 555

View all →
HolderValue% of shares
BlackRock, Inc.$1.17B10.56%
Vanguard Group Inc$1.08B9.36%
Dodge & Cox$866.04M7.53%
Primecap Management CO/CA$864.67M7.52%
Norges Bank$447.57M3.89%
State Street Corporation$446.37M4.03%
AQR Capital Management, LLC$429.35M3.97%
Viking Global Investors LP$398.94M3.65%
Geode Capital Management, LLC$215.81M1.97%
Dimensional Fund Advisors LP$197.40M1.72%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Norges Bank
13F manager
ExitCommon stock$-447.57M-7.5M
-100.00%
0
high
Q2 2024
as of
Barclays PLC
13F manager
TrimCommon stock$-340.53M-4.1M
-78.72%
1,118,380
0.58% of shares
high
Q3 2023
as of
Barclays PLC
13F manager
AddCommon stock$257.64M+2.9M
+109.42%
5,573,157
2.88% of shares
high
Q4 2025
as of
Norges Bank
13F manager
AddCommon stock$250.95M+4.2M
+127.64%
7,531,080
3.89% of shares
high
Q2 2023
as of
Barclays PLC
13F manager
AddCommon stock$91.57M+1.1M
+65.83%
2,661,271
1.37% of shares
high
Q1 2026
as of
Balyasny Asset Management L.P.
13F manager
NewCommon stock$76.98M+1.4M
1,362,752
0.70% of shares
high
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon stock$74.96M+1.3M
+6.85%
20,445,212
10.56% of shares
high
Q3 2024
as of
Barclays PLC
13F manager
TrimCommon stock$-58.40M-831K
-74.29%
287,591
0.15% of shares
high

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
BlackRock, Inc.Passive13G/A—17,560,751—
Vanguard Capital ManagementPassive13G—10,113,219—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
BMRN——09061G101—